Chronic atrial fibrillation b associated with an increased risk of stroke. In elderly patients with thyrotoxicosis, atrial fibrillation is frequently encountered, and the true risk of cerebrovascular events in these patients is controversial. We retrospectively studied 610 patients with initially untreated thyrotoxicosis, 91 (14.9%) of whom had atrial fibrillation, with the highest frequency in the elderly patients. The risk of cerebrovascular events, with special attention to the first year after the diagnosis of thyrotoxicosis, was calculated using logistic regression methods with age, sex, and atrial fibrillation as independent variables. Only age was an important risk factor (p<0.005), whereas sex and atrial fibrillation were not significant (p = 0.09 and p = 0.17, respectively) as independent risk factors. This is contrary to other studies of patients with thyrotoxic atrial fibrillation, and the need for further clarification of this issue is clear. From our study the indication for prophylactic treatment with anticoagulants for prevention of stroke in thyrotoxic a trial fibrillation seems doubtful, especially as no controlled studies of such treatment in patients with atrial fibrillation are currently available. © 1988 American Heart Association, Inc.
CITATION STYLE
Hansen, J. M., & Petersen, P. (1988). Stroke in thyrotoxicosis with atrial fibrillation. Stroke, 19(1), 15–18. https://doi.org/10.1161/01.str.19.1.15
Mendeley helps you to discover research relevant for your work.